Chetna Kharbanda
New Delhi, DL, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
In silico designing, in vitro and in vivo evaluation of potential PPAR-γ agonists derived from aryl propionic acid scaffold.
Journal: Bioorganic chemistry
Published: July 13, 2020
Novel 2,4-dichlorophenoxy acetic acid substituted thiazolidin-4-ones as anti-inflammatory agents: Design, synthesis and biological screening.
Journal: Bioorganic & medicinal chemistry letters
Published: June 21, 2016
Novel Piperine Derivatives with Antidiabetic Effect as PPAR-γ Agonists.
Journal: Chemical biology & drug design
Published: December 09, 2015
Antidiabetic effect of novel benzenesulfonylureas as PPAR-γ agonists and their anticancer effect.
Journal: Bioorganic & medicinal chemistry letters
Published: March 05, 2015
Design, synthesis and biological evaluation of piperic acid triazolyl derivatives as potent anti-inflammatory agents.
Journal: European journal of medicinal chemistry
Published: September 17, 2014
Synthesis and evaluation of pyrazolines bearing benzothiazole as anti-inflammatory agents.
Journal: Bioorganic & medicinal chemistry
Published: August 22, 2014
Design, Synthesis, and Biological Evaluation of Thiazolidine-2,4-dione Conjugates as PPAR-γ Agonists.
Journal: Archiv der Pharmazie
Published: July 14, 2014
Novel benzenesulfonylureas containing thiophenylpyrazoline moiety as potential antidiabetic and anticancer agents.
Journal: Bioorganic & medicinal chemistry letters
Published: June 14, 2014
Design, synthesis, in silico molecular docking and biological evaluation of novel oxadiazole based thiazolidine-2,4-diones bis-heterocycles as PPAR-γ agonists.
Journal: European journal of medicinal chemistry
Published: May 30, 2014
Design and Synthesis of Butenolide-based Novel Benzyl Pyrrolones: Their TNF-α based Molecular Docking with In vivo and In vitro Anti-inflammatory Activity.
Journal: Chemical biology & drug design
Published: May 23, 2014
Synthesis of novel 2-mercaptobenzoxazole based 1,2,3-triazoles as inhibitors of proinflammatory cytokines and suppressors of COX-2 gene expression.
Journal: European journal of medicinal chemistry
Published: January 21, 2014
Last Updated: 09/26/2026